Literature DB >> 34458885

Opioid withdrawal produces sex-specific effects on fentanyl-vs.-food choice and mesolimbic transcription.

E Andrew Townsend1, R Kijoon Kim2, Hannah L Robinson1, Samuel A Marsh1, Matthew L Banks1, Peter J Hamilton2.   

Abstract

BACKGROUND: Opioid withdrawal is a key driver of opioid addiction and an obstacle to recovery. However, withdrawal effects on opioid reinforcement and mesolimbic neuroadaptation are understudied and the role of sex is largely unknown.
METHODS: Male (n=13) and female (n=12) rats responded under a fentanyl-vs.-food "choice" procedure during daily 2h sessions. In addition to the daily choice sessions, rats were provided extended access to fentanyl during 12h self-administration sessions. After two weeks of this self-administration regimen, the nucleus accumbens (NAc) and ventral tegmental area (VTA) of a subset of rats were subjected to RNA sequencing. In the remaining rats, a third week of this self-administration regimen was conducted, during which methadone effects on fentanyl-vs.-food choice were determined.
RESULTS: Prior to opioid dependence, male and female rats similarly allocated responding between fentanyl and food. Abstinence from extended fentanyl access elicited similar increases in somatic withdrawal signs in both sexes. Despite similar withdrawal signs and extended access fentanyl intake, opioid withdrawal was accompanied by a maladaptive increase in fentanyl choice in males, but not females. Behavioral sex differences corresponded with a greater number of differentially expressed genes in the NAc and VTA of opioid-withdrawn females relative to males. Methadone blocked withdrawal-associated increases in fentanyl choice in males, but failed to further decrease fentanyl choice in females.
CONCLUSIONS: These results provide foundational evidence of sex-specific neuroadaptations to opioid withdrawal, which may be relevant to the female-specific resilience to withdrawal-associated increases in opioid choice and aid in the identification of novel therapeutic targets.

Entities:  

Keywords:  Opioid withdrawal; RNA sequencing; decision making; nucleus accumbens; self-administration; sex differences

Year:  2021        PMID: 34458885      PMCID: PMC8389189          DOI: 10.1016/j.bpsgos.2021.04.009

Source DB:  PubMed          Journal:  Biol Psychiatry Glob Open Sci        ISSN: 2667-1743


  7 in total

1.  Lack of effect of the nociceptin opioid peptide agonist Ro 64-6198 on pain-depressed behavior and heroin choice in rats.

Authors:  Megan Jo Moerke; S Stevens Negus; Matthew L Banks
Journal:  Drug Alcohol Depend       Date:  2021-12-30       Impact factor: 4.492

2.  Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats.

Authors:  E Andrew Townsend; Bruce E Blough; David H Epstein; S Stevens Negus; Yavin Shaham; Matthew L Banks
Journal:  Neuropsychopharmacology       Date:  2022-07-29       Impact factor: 8.294

3.  Gene-Targeted, CREB-Mediated Induction of ΔFosB Controls Distinct Downstream Transcriptional Patterns Within D1 and D2 Medium Spiny Neurons.

Authors:  Casey K Lardner; Yentl van der Zee; Molly S Estill; Hope G Kronman; Marine Salery; Ashley M Cunningham; Arthur Godino; Eric M Parise; Jee Hyun Kim; Rachael L Neve; Li Shen; Peter J Hamilton; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2021-07-01       Impact factor: 12.810

4.  Transcriptomics in the nucleus accumbens shell reveal sex- and reinforcer-specific signatures associated with morphine and sucrose craving.

Authors:  Hannah L Mayberry; Charlotte C Bavley; Reza Karbalaei; Drew R Peterson; Angela R Bongiovanni; Alexandra S Ellis; Sara H Downey; Andre B Toussaint; Mathieu E Wimmer
Journal:  Neuropsychopharmacology       Date:  2022-02-21       Impact factor: 8.294

5.  Logical fallacies and misinterpretations that hinder progress in translational addiction neuroscience.

Authors:  Justin C Strickland; William W Stoops; Matthew L Banks; Cassandra D Gipson
Journal:  J Exp Anal Behav       Date:  2022-04-01       Impact factor: 2.215

Review 6.  Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse.

Authors:  Ying Han; Lu Cao; Kai Yuan; Jie Shi; Wei Yan; Lin Lu
Journal:  Neurosci Bull       Date:  2022-05-15       Impact factor: 5.271

7.  Sex- and Dose-Dependent Differences in the Development of an Addiction-Like Phenotype Following Extended-Access Fentanyl Self-Administration.

Authors:  Eleanor Blair Towers; Ben Setaro; Wendy J Lynch
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.